Although we could demonstrate a significantly impaired relative level of CD4 + T-cells in our participants with DMcompared to without DM (47.2% vs. 49.7%), the resulting clinical relevance of this difference seems unlikely and might explain the non-existent difference in terms of the anti-SARS-CoV-2-titers. The gene discussed is CD4; the disease is diabetes mellitus.